The Liver Meeting 2016: American Association for the Study of Liver Diseases (AASLD)
November 11 - 15, 2016; Boston, Massachusetts
- AASLD Cenicriviroc Improves Fibrosis in Patients With Fatty Liver
- AASLD Combo Shows Promise for Hep C Patients With Renal Disease
- AASLD Novel Treatment Could Lead to Functional Control of Hep B
- AASLD Fatty Liver Disease in Teens Parallels Obesity Rise
Popular AASLD 2015 News
Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.
Nancy Reau, MD
Rush University Medical Center, Chicago, Illinois
Presentation: Hepatitis C treatment duration: How short can it be?
Date: November 13, 2016